Hazel AI vs a2z Radiology AI
Side-by-side comparison of AI visibility scores, market position, and capabilities
Autonomous AI modernization platform using multi-agent orchestration for enterprise development transformations. Delivers $20-50M annual outcomes per project.
About
Hazel AI was founded to solve one of enterprise technology's most persistent and costly problems: the accumulation of aging, complex legacy codebases that organizations cannot afford to maintain but cannot afford to abandon. The company's mission is to automate the modernization of enterprise software through autonomous AI agents that understand, transform, and re-architect legacy systems at a speed and scale that human engineering teams cannot match. Its core technology relies on multi-agent orchestration to analyze existing code, generate transformation plans, and execute migrations across large, heterogeneous code environments.\n\nHazel AI's platform targets large enterprises with significant investments in legacy systems across mainframe, COBOL, Java, and other aging technology stacks. Rather than generating incremental code suggestions, Hazel operates as a full transformation engine capable of handling end-to-end modernization engagements. The platform coordinates multiple specialized AI agents, each responsible for distinct stages of the transformation process, enabling parallel execution across millions of lines of code.\n\nHazel AI positions each engagement as a high-ROI initiative, claiming $20 to $50 million in annual outcomes per customer through reduced maintenance costs, improved developer velocity, and decommissioned legacy infrastructure. This outcome-based framing differentiates Hazel from tool vendors and aligns it more closely with systems integrators, allowing it to command premium pricing. The platform addresses a multi-hundred-billion-dollar global market in legacy modernization, where enterprises are increasingly motivated to accelerate transformation as AI raises the competitive cost of technical debt.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
About
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.